Skip to main content

Thymus Transplantation

Publication ,  Journal Article
Louise Markert, M
August 12, 2014

Thymus transplantation is an experimental procedure in which allogeneic, cultured, postnatal thymus tissue is transplanted into an athymic infant. Almost all transplant recipients are infants with complete DiGeorge anomaly. The donor thymus is obtained as discarded tissue from pediatric heart surgery after informed consent. It is sectioned, and maintained in culture while donor screening is performed. After 2-3 weeks in culture, the thymus tissue is transplanted into the quadriceps muscle of the athymic infant under general anesthesia in the operating room. Temporary immunosuppression is required in approximately half of transplant recipients. In a series of 67 consecutive patients, the 1-year survival rate was 76%. The median age of survivors is 7.8 years. Naïve CD4+ and CD8+ T cells develop over the first 6-9 months. Immunosuppression, immunoglobulin replacement therapy, and Pneumocystis prophylaxis are discontinued at approximately 1 year post-transplantation.

Duke Scholars

DOI

Publication Date

August 12, 2014

Start / End Page

1059 / 1067
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Louise Markert, M. (2014). Thymus Transplantation, 1059–1067. https://doi.org/10.1016/B978-0-12-405546-9.00060-1
Louise Markert, M. “Thymus Transplantation,” August 12, 2014, 1059–67. https://doi.org/10.1016/B978-0-12-405546-9.00060-1.
Louise Markert M. Thymus Transplantation. 2014 Aug 12;1059–67.
Louise Markert, M. Thymus Transplantation. Aug. 2014, pp. 1059–67. Scopus, doi:10.1016/B978-0-12-405546-9.00060-1.
Louise Markert M. Thymus Transplantation. 2014 Aug 12;1059–1067.

DOI

Publication Date

August 12, 2014

Start / End Page

1059 / 1067